You searched for liver disease | Page 63 of 432

NULISAseq CNS Disease Panel 120 Expanded with Blood-Based Brain-Derived pTau Assays

Alamar Biosciences has expanded its NULISAseq CNS Disease Panel 120 to include highly sensitive, blood-based assays.

A new peer-reviewed study validates Vibrant Sciences’ microarray, enabling fast, accurate, scalable detection of over 17 tickborne pathogens.

Posted by Chris Wolski | May 12, 2025 | Cervical (HPV) |

Teal Health has received FDA approval for the Teal Wand, a prescription-based self-collection device for cervical cancer screening.

Researchers are uncovering how the deadly parasite E. histolytica kills human cells and evades the immune system.

ALPCO has launched its FDA-cleared Calprotectin Immunoturbidimetric Assay in Europe and begun a pivotal U.S. clinical trial.